Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Céline Labeyrie

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Neurology|June 1, 2021
Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathyMarie Subréville, Nathalie Bonello-Palot, Douniazed Yahiaoui, et al.
European Journal of Neurology|March 20, 2026
Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case SeriesJulian Theuriet, Maud Michaud, Guillaume Fargeot, et al.
Journal of Neurology|May 20, 2024
Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndromeMartin Coly, David Adams, Shahram Attarian, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 21, 2020
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteinsLudivine Kouton, José Boucraut, Jérome Devaux, et al.
Journal of Neurology|July 18, 2020
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 seraEmilien Delmont, Alexandre Brodovitch, Ludivine Kouton, et al.
European Journal of Neurology|August 1, 2025
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral NeuropathyPauline Jaubert, Camille Loret, Tanya Stojkovic, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
Advances in Therapy|February 19, 2025
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in FranceJérôme de Sèze, Pierre Labauge, Roland Liblau, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Neurology|June 1, 2021
Genotype-phenotype correlation in French patients with myelin protein zero gene-related inherited neuropathyMarie Subréville, Nathalie Bonello-Palot, Douniazed Yahiaoui, et al.
European Journal of Neurology|March 20, 2026
Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case SeriesJulian Theuriet, Maud Michaud, Guillaume Fargeot, et al.
Journal of Neurology|May 20, 2024
Clinical, paraclinical and outcome features of 166 patients with acute anti-GQ1b antibody syndromeMartin Coly, David Adams, Shahram Attarian, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 21, 2020
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteinsLudivine Kouton, José Boucraut, Jérome Devaux, et al.
Journal of Neurology|July 18, 2020
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 seraEmilien Delmont, Alexandre Brodovitch, Ludivine Kouton, et al.
European Journal of Neurology|August 1, 2025
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral NeuropathyPauline Jaubert, Camille Loret, Tanya Stojkovic, et al.
Neurology|September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life StudyMarion Hay, Fabien Rollot, Romain Casey, et al.
Advances in Therapy|February 19, 2025
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in FranceJérôme de Sèze, Pierre Labauge, Roland Liblau, et al.
JAMA Neurology|September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in FranceSandra Vukusic, Fabien Rollot, Romain Casey, et al.
Neurology|July 14, 2019
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosisDavid-Axel Laplaud, Romain Casey, Laetitia Barbin, et al.
Pageof 5